Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Method and device for checking the electrical insulation as well as a method and system for producing photovoltaic modules
Fixing device including resistor layers having volume resistivity and image forming apparatus having fixing device
Light emitting device and illumination apparatus
Paint producing method and paint producing system
Electromagnetic interference reduction apparatus
Bumper for motor vehicle
Gripping device for tubular objects
  Randomly Featured Patents
Wind cap for buildings
Triazole derivatives
Air-pruning tray/container matrix transfer and transplanting system and methods
Method, system, and article of manufacture for self-servowriting a disk
Method for recording data to a write once disc
Process for producing alkyl tin alkoxide compound and process for producing carbonic acid ester using said compound
System and method for detecting moisture
Retaining device
Interactive firmware recovery